Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T15:41:09.036Z.
Calculation as of: 2026-10-06T15:41:09.036Z.
Quote observation: 2026-10-06T15:40:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$1.47B
PS Ratio
73.51
TTM Avg
162.26
3Y Avg
112.18
5Y Avg
112.18
Market Cap
$1.51B
PS Ratio
0.99
TTM Avg
1.17
3Y Avg
0.89
5Y Avg
0.83
Market Cap
$1.46B
PS Ratio
0.78
TTM Avg
0.80
3Y Avg
0.61
5Y Avg
0.64
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.49B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.49B | 3.65 | 3.01 | 4.89 | 7.22 |
| GH Research PLC (GHRS)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | 73.51 | 162.26 | 112.18 | 112.18 |
| Phibro Animal Health Corporation (PAHC)vs › | $1.51B | 0.99 | 1.17 | 0.89 | 0.83 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 0.78 | 0.80 | 0.61 | 0.64 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 14.38 | 10.39 | 7.65 | 6.59 |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 6.05 | 6.28 | 11.75 | 20.01 |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 1.82 | 1.16 | 0.80 | 3.00 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.42B | N/A | N/A | N/A | N/A |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
